Add BrightSurf on Google Email

Study on E. coli outbreak in the UK demonstrates increasing impact of climate change on public health and food security

A study on the UK E. coli outbreak identified contaminated lettuce as the primary source of infection, with heavy rainfall carrying STEC from animal feces to the crops. The investigation demonstrated the value of a One Health approach in predicting and preventing future outbreaks.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeObservational study·DateSep 5, 2024

First narrow-spectrum antibiotic successfully eliminates Fusobacterium nucleatum in breakthrough study at the ADA Forsyth institute

A new narrow-spectrum antibiotic, FP 100, has been found to effectively eliminate Fusobacterium nucleatum without harming the oral or gut microbiomes. This breakthrough discovery holds significant implications for treating severe gum disease and preventing related systemic conditions such as colon cancer and Alzheimer's disease.

SourceForsyth Institute·JournalJournal of Oral Microbiology·TypeExperimental study·DateSep 4, 2024

Gut bioelectricity provides a path for bad bacteria to cause diseases

A team of researchers at UC Davis Health discovered a novel bioelectrical mechanism that allows Salmonella bacteria to navigate the gut lining and find vulnerable entry points. The study found that Salmonella bacteria detect electric signals in FAE, which helps them move towards openings in the gut where they can enter.

SourceUniversity of California - Davis Health·JournalNature Microbiology·TypeExperimental study·DateAug 20, 2024

Predation drives opportunistic bacteria to become more virulent

A study published in Genome Biology and Evolution found that predation by protists increases the virulence of opportunistic pathogens like Serratia marcescens. The presence of the predator Tetrahymena thermophila led to stronger biofilm formation and greater antimicrobial resistance, resulting in higher mortality in honey bees.

SourceSMBE Journals (Molecular Biology and Evolution and Genome Biology and Evolution)·JournalGenome Biology and Evolution·TypeExperimental study·DateAug 20, 2024

Pumpkin disease not evolving, could make a difference for management

The Xanthomonas cucurbitae pathogen that causes bacterial spot has remained genetically uniform across the Midwest, with most isolates sharing over 99% identical DNA sequences. This lack of diversification may hinder the pathogen's ability to evolve and could be leveraged for developing disease-resistant crops.

ASU researchers gain insight into how a deadly strain of salmonella fine-tunes its infection tactics

Researchers have gained insight into how a deadly strain of salmonella adapts to invasion, flourishing in hostile environments and evading immune defenses. The study sheds light on the role of fluid shear forces in bacterial behavior, which may accelerate the design of new therapies for life-threatening infections.

SourceArizona State University·JournalGut Microbes·TypeExperimental study·DateJun 14, 2024

The effect of combinations of antibiotics and natural products on the antimicrobial resistance of Staphylococcus aureus and Pseudomonas aeruginosa

Researchers tested seven antibiotics in combination with various natural compounds, finding synergistic effects against multidrug-resistant bacteria. The study suggests combining antibiotics with plant extracts or phytochemicals could be a promising strategy to combat antimicrobial resistance.

SourceBentham Science Publishers·JournalThe Open Infectious Diseases Journal·DateMay 27, 2024

Dartmouth-led study provides new insights into phage therapy design

A new Dartmouth-led study has provided new insights into the therapeutic potential of bacteriophage therapy for treating diseases like cystic fibrosis. Researchers found that respiratory epithelial cells sense and respond to therapeutic phages, and interactions between phages and epithelial cells are heterogenous in nature.

SourceThe Geisel School of Medicine at Dartmouth·JournalPLOS Biology·TypeExperimental study·DateMay 15, 2024

Marine bacteria team up to produce a vital vitamin

Researchers discovered that two species of marine bacteria work together to produce vitamin B12, essential for metabolism and survival of many marine organisms. The bacteria release building blocks into the water, which are then combined to form the vitamin through a complex process involving viral infection.

SourceUniversity of Oldenburg·JournalNature·TypeExperimental study·DateMay 8, 2024

Characterized extracts of the tropical red seaweed Acanthophora spicifera protect Ostrea edulis larvae against Vibrio coralliilyticus

Researchers discovered that Acanthophora spicifera extracts inhibit Vibrio coralliilyticus growth and improve survival rates in Ostrea edulis larvae. The study highlights the potential of natural compounds from seaweeds as an alternative to antibiotics for aquaculture disease control.

SourceEscuela Superior Politecnica del Litoral·JournalAquaculture·TypeExperimental study·DateApr 25, 2024

Exploring the relationship between HIV pre-exposure prophylaxis and the incidence of chlamydia, gonorrhea and syphilis – findings from Denmark

A Danish study found that PrEP use was associated with a more than twofold increase in chlamydia, gonorrhea, and syphilis diagnoses. The researchers suggest that changes in sexual risk-taking may lead people to seek PrEP rather than increased risks.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeData/statistical analysis·DateMar 28, 2024

What makes a pathogen antibiotic-resistant?

A new study published in npj Antimicrobials and Resistance found that pathogenic bacteria E. coli and A. baumannii employ shared and unique mechanisms to acquire resistance to antibiotics ciprofloxacin and GP6. The researchers developed a method to track the acquisition of drug resistance using whole genome sequencing, which revealed t...

SourceSanford Burnham Prebys·Journalnpj Antimicrobials and Resistance·TypeExperimental study·DateMar 7, 2024

Engineering a coating for disease-free produce

Researchers at Texas A&M University have developed a coating that bolsters the safety of fresh produce and provides enhanced protection against bacteria and fungi. The coating combines wax with nano-encapsulated cinnamon-bark essential oil in protein carriers to enhance antibacterial properties.

SourceTexas A&M University·JournalCurrent Research in Food Science·DateFeb 20, 2024

Gargling away the bad bacteria in type 2 diabetes

Researchers from Osaka University found that gargling with an antiseptic mouthwash can reduce periodontitis-related bacteria in patients with type 2 diabetes. This simple method may improve the lives of people with periodontitis-linked diseases such as diabetes, dementia, and cardiovascular disease.

SourceOsaka University·JournalScientific Reports·TypeObservational study·DateFeb 14, 2024

New study finds corn genome can gang up on multiple pathogens at once

Researchers at the University of Illinois have identified genomic regions associated with resistance to four diseases in corn: Goss's wilt, gray leaf spot, northern corn leaf blight, and southern corn leaf blight. The study found that multiple genes working together can provide durable resistance against different pathogens.

New treatment options for bloodstream infections

Researchers have gained decisive insights into treating bloodstream infections with Staphylococcus aureus, finding that early oral antibiotic therapy is as effective and safe as intravenous standard treatment. This approach enables easier treatment and faster discharge for patients at low risk of developing infectious complications.

SourceUniversity of Cologne·JournalThe Lancet Infectious Diseases·TypeRandomized controlled/clinical trial·DateJan 18, 2024

A new approach can address antibiotic resistance to Mycobacterium abscessus

Researchers at St. Jude Children's Research Hospital have designed a new version of the drug spectinomycin that overcomes efflux, a key mechanism driving antibiotic resistance in Mab infections. The modified compound, eAmSPCs, shows enhanced antimicrobial efficacy and works well with various classes of antibiotics.

SourceSt. Jude Children's Research Hospital·JournalProceedings of the National Academy of Sciences·DateJan 5, 2024

Taking antibiotics back in time

A team of researchers successfully synthesized a 1.5-million-year-old antibiotic called paleomycin, which displays potent properties against human pathogens. By tracing the evolutionary path of glycopeptide antibiotics, the team gained insights into the development of new drugs and uncovered a common precursor molecule.

SourceCluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)·JournalNature Communications·TypeComputational simulation/modeling·DateNov 30, 2023

Unlocking long-term genetic memory: Dormant bacterial spores offer key insights into evolutionary survival strategies

Researchers discover a central chromosomal domain that enables dormant spores to revive and activate essential genes, shedding light on bacterial survival in harsh conditions. The study's findings have broader implications for sustaining long-term transcriptional programs across diverse organisms.

SourceThe Hebrew University of Jerusalem·JournalMolecular Cell·TypeExperimental study·DateNov 27, 2023

Consumption of antibiotics in the community back to pre-pandemic levels in the European Union and European Economic Area

Community antibiotic consumption in the EU increased by 18.8% between 2021 and 2022, reversing a significant decline seen during the pandemic. The resurgence of infections may have contributed to the rebound, but highlights the need for continued prudent use of antibiotics.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeData/statistical analysis·DateNov 17, 2023

Novel C. diff structures are required for infection, offer new therapeutic targets

Researchers at Vanderbilt University Medical Center discovered iron storage 'spheres' inside C. diff bacteria, which are crucial for infection and offer new targets for antibacterial drugs. The study, published in Nature, also reveals that bacteria may compartmentalize biochemical processes in a way similar to eukaryotic cells.

SourceVanderbilt University Medical Center·JournalNature·TypeExperimental study·DateNov 15, 2023

New antibodies neutralize resistant bacteria

Researchers have discovered highly effective antibodies against P. aeruginosa that can block its type III secretion system and are effective against highly resistant bacteria. These 'pathoblockers' offer a potential therapeutic approach for treating acute and chronic infections with multi-resistant pathogens.

SourceUniversity of Cologne·JournalCell·TypeExperimental study·DateNov 2, 2023